Biopartners Holdings AG Purchased by Bioton S.A.
Biopartners is a biotechnology company concentrating on the development of innovative drugs and biopharmaceuticals, where significant market opportunities exist. According to the company, the terms of the deal ensure that all Biopartners' operations remain untouched, with all drug development projects continuing as before under the same management.
Bioton S.A. is a Polish company in the biotechnology sector, manufacturing modern drugs, including recombinant human insulin and its pharmaceutical forms, as well as preparations from the cephalosporine, aminoglycoside and macrolide groups.
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.